Loading chat...

AL HB197

Bill

Status

Introduced

2/11/2020

Primary Sponsor

Danny Garrett

Click for details

Origin

House of Representatives

Regular Session 2020

AI Summary

HB197 Summary

  • Amends Alabama Code to expand the scope of optometry practice to include prescribing and administering narcotic analgesics (Schedule III-V) and steroid pharmaceutical agents for eye and adjacent structure treatment.

  • Prohibits optometrists from prescribing Schedule I and II narcotics and limits other Schedule III agents to prescriptions not exceeding 96 hours, except hydrocodone which is prohibited.

  • Authorizes optometrists to perform specific procedures including injections (excluding posterior chamber), chalazion removal, skin lesion biopsy, laser capsulotomy, laser trabeculoplasty, laser peripheral iridotomy, and corneal crosslinking.

  • Explicitly prohibits optometrists from performing eyeball injections, cataract surgery, muscle surgery, retinal surgery, radial keratotomy, refractive laser surgery, cryosurgery, or invasive ophthalmic surgery requiring general anesthesia.

  • Establishes the Alabama Board of Optometry as the sole authority to determine what constitutes optometry practice and grants it exclusive jurisdiction to regulate the profession, with power to issue advisory opinions and declaratory rulings; clarifies board status as a certifying board under the Uniform Controlled Substances Act with specified limitations.

Legislative Description

Optometrists, practice of optometry defined, Board of Optometry to regulate, Secs. 20-2-2, 34-22-1 am'd.

Optometry, Alabama Board of

Last Action

Read for the first time and referred to the House of Representatives committee on Health

2/11/2020

Committee Referrals

Health2/11/2020

Full Bill Text

No bill text available